Monday, January 13, 2014

NanoString Seeks $55M More In Secondary IPO

Seattle-based life sciences product developer NanoString Technologies said in a filing today that it plans to offer up $55M more in a secondary, public stock offering. The company said the new funds will go towards further commercialization of its lead product, Prosign, including hiring a dedicated sales force. The filing comes six months after a fairly lackluster IPO for the company.